Warning and Advisories for Healthcare Providers > ADR that result in revision of patient information or suspension of marketing authorisation

ADR that result in revision of patient information   The United Kingdom: Abrysvo▼(Pfizer RSV vaccine) and Arexvy▼(GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults       Attachment: The United Kingdom: Abrysvo▼(Pfizer RSV vaccine) and Arexvy▼(GSK RSV vaccine): be alert to a small risk of Guillain-Barré syndrome following vaccination in older adults   Related Information: Australia: Updated warnings for Respiratory Syncytial Virus (RSV) vaccines Arexv... Posted 2025-05-19 FDA requires Guillain-Barré Syndrome (GBS) warning in the prescribing informatio... Posted 2025-01-08 The United States: FDA requires Guillain-Barré Syndrome (GBS) warning in the pre... Posted 2025-01-08